RESUMO
3,4 Methylenedioxymethamphetamine (MDMA)-assisted therapy has been recently found to be highly effective for treatment of posttraumatic stress disorder (PTSD). Previous studies have been inconclusive in elucidating potential MDMA genotoxicity. We performed three regulatory compliant studies to investigate the potential of genotoxic effects of MDMA treatment in humans: (1) an in vitro bacterial reverse mutation (Ames) assay, (2) an in vitro chromosome aberration test in Chinese hamster ovary cells, and (3) an in vivo micronucleus study in male Sprague Dawley rats. MDMA was found to not have genotoxic effects in any of the assays at or above clinically relevant concentrations.
Assuntos
Células CHO/efeitos dos fármacos , Aberrações Cromossômicas/efeitos dos fármacos , Escherichia coli/efeitos dos fármacos , N-Metil-3,4-Metilenodioxianfetamina/toxicidade , Neurotransmissores/toxicidade , Salmonella typhimurium/efeitos dos fármacos , Transtornos de Estresse Pós-Traumáticos/tratamento farmacológico , Animais , Cricetulus , Feminino , Masculino , Testes de Mutagenicidade , N-Metil-3,4-Metilenodioxianfetamina/administração & dosagem , Neurotransmissores/administração & dosagem , Ratos , Ratos Sprague-DawleyRESUMO
Benzodiazepines are highly effective in combating anxiety; however, they have considerable adverse effects, so it is important to discover new safe anxiolytic agents. This study was designed to investigate the effect of the natural product 2-hydroxy-3,4,6-trimethoxyacetophenone (HTMCX) on anxiety and seizure behavior in adult zebrafish and its possible mechanisms of action. The acute toxicity of 96 h of HTMCX was analyzed, and the open and light/dark field tests (n = 6 animals/group) were used to assess the anxiety behavior of animals treated with HTMCX. In addition, the mechanisms of action were investigated with antagonists of the GABAA, 5-HT receptors, and molecular anchorage study. Pentylenetetrazole (PTZ) was used to induce seizure by immersion. As a result, acetophenone HTMCX (1, 3 and 10 mg/kg; v.o.) was non-toxic and affected locomotor activity. The higher doses (3 and 10 mg/kg; v.o.) produced signs of anxiolytic action in the light/dark test, and this effect was reversed by the pizotifen (antagonist 5HTR1 and 5HTR2A/2C), having the potential to form a complex with 5HTR1B. However, the anxiolytic effect of HTMCX has not been abolished by flumazenil (antagonist GABAA), cyproheptadine (antagonist 5HTR2A), and granisetron (antagonist 5HTR3A/3B). Therefore, HTMCX demonstrated an anxiolytic effect, suggesting that the 5HTR1 and 5HTR2C receptors may be involved in the pharmacological performance of this acetophenone in the central nervous system.
Assuntos
Acetofenonas/uso terapêutico , Ansiolíticos/uso terapêutico , Ansiedade/tratamento farmacológico , Produtos Biológicos/uso terapêutico , Croton , Neurotransmissores/uso terapêutico , Acetofenonas/farmacologia , Acetofenonas/toxicidade , Animais , Ansiolíticos/farmacologia , Ansiolíticos/toxicidade , Ansiedade/metabolismo , Produtos Biológicos/farmacologia , Produtos Biológicos/toxicidade , Feminino , Masculino , Simulação de Acoplamento Molecular , Neurotransmissores/farmacologia , Neurotransmissores/toxicidade , Pentilenotetrazol , Receptores de Serotonina/metabolismo , Convulsões/induzido quimicamente , Convulsões/tratamento farmacológico , Convulsões/metabolismo , Serotonina/metabolismo , Peixe-ZebraRESUMO
One of the most widely used flavour enhancers in the food industry is monosodium glutamate (MSG). MSG consumption has been on an upward trend, worrying in terms of potential toxic effects. This review is focused on the long-term toxicity of MSG and the experimental evidence that supports it. The article's primary purpose was to survey recently published data regarding the consumption of MSG within safe limits. The administered doses in animal models are very varied and have given rise to controversy. Also, the paper comprises pathways to lower MSG toxicity and highlight other underexploited biological effects, as anti-cancer potential. The administration of MSG, combined with various compounds, has been shown benefit against toxic effects. Several recent studies have identified a possible mechanism that recommends MSG and some derivatives as potential anti-cancer agents. New anti-cancer compounds based on the glutamic acid structure must be studied and further exploited. International regulations require harmonization of safe doses of MSG based on current scientific studies. Replacing MSG with other umami flavour enhancers may be a safer alternative for human health in the future. The biological consequences of MSG consumption or therapeutical administration have not been fully deciphered yet.
Assuntos
Antineoplásicos/toxicidade , Aromatizantes/toxicidade , Neurotransmissores/toxicidade , Glutamato de Sódio/toxicidade , Animais , Antineoplásicos/metabolismo , Antineoplásicos/uso terapêutico , Antioxidantes/farmacologia , Aromatizantes/metabolismo , Glutamatos/uso terapêutico , Glutamina/metabolismo , Humanos , Neurotransmissores/fisiologia , Estresse Oxidativo/efeitos dos fármacos , Glutamato de Sódio/metabolismoRESUMO
AIM: The current study aims to investigate the impact of paradoxical (REM) sleep deprivation and/or epileptic seizures on rat's cortical brain tissues. MAIN METHODS: Animals were divided into four groups; control, epileptic, REM sleep deprived and epileptic subjected to REM sleep deprivation. Electrocorticogram (ECoG) signals were recorded and quantitatively analyzed for each group. Concentrations of amino acid neurotransmitters; proinflammatory cytokines; and oxidative stress parameters; and acetylcholinesterase activity were determined in the cortex of the animals in different groups. KEY FINDINGS: Results showed significant variations in the spectral distribution of ECoG waves in the epilepsy model, 24- and 48-hours of REM sleep deprivation and their combined effects indicating a state of cortical hyperexcitability. Significant increases in NO and taurine and significant decrement in glutamine, GABA and glycine were determined. In REM sleep deprived rats significant elevation in glutamate, aspartate, glycine and taurine and a significant lowering in GABA were obtained. This was accompanied by significant reduction in AchE and IL-ß. In the cortical tissue of epileptic rats deprived from REM sleep significant increases in lipid peroxidation, TNF-α, IL-1ß, IL-6 and aspartate and a significant reduction in AchE were observed. SIGNIFICANCE: The present data indicate that REM sleep deprivation induces an increase in lipid peroxidation and storming in proinflammatory cytokines in the cortex of rat model of epilepsy during SRS. These changes are associated with a decreased seizure threshold as inferred from the increase in alpha and Beta waves and a decrease in Delta waves of ECoG.
Assuntos
Encéfalo/patologia , Neurotransmissores/toxicidade , Estresse Oxidativo/efeitos dos fármacos , Convulsões/complicações , Privação do Sono/complicações , Sono REM/efeitos dos fármacos , Animais , Encéfalo/efeitos dos fármacos , Eletrofisiologia , Peroxidação de Lipídeos , Masculino , Ratos , Ratos WistarRESUMO
Methamphetamine (MA), as massively abused psychoactive stimulant, has been associated with many neurological diseases. It has various potent and neurotoxic properties. There are many mechanisms of action that contribute to its neurotoxic and degenerative effects, including excessive neurotransmitter (NEU) release, blockage of NEU uptake transporters, degeneration of NEU receptors, process of oxidative stress etc. MA intoxication is caused by blood-brain barrier disruption resulted from MA-induced oxidation stress. In our laboratory we constantly work on animal research of MA. Our current interest is to investigate processes of MA-induced alteration in neurotransmission, especially during development of laboratory rat. This review will describe current understanding in role of NEUs, which are affected by MA-induced neurotoxicity caused by altering the action of NEUs in the central nervous system (CNS). It also briefly brings information about NEUs development in critical periods of development.
Assuntos
Estimulantes do Sistema Nervoso Central/toxicidade , Sistema Nervoso Central/efeitos dos fármacos , Metanfetamina/toxicidade , Neurogênese/efeitos dos fármacos , Síndromes Neurotóxicas/etiologia , Neurotransmissores/toxicidade , Transmissão Sináptica/efeitos dos fármacos , Animais , Comportamento Animal/efeitos dos fármacos , Sistema Nervoso Central/crescimento & desenvolvimento , Sistema Nervoso Central/metabolismo , Humanos , Síndromes Neurotóxicas/metabolismo , Síndromes Neurotóxicas/patologia , RatosRESUMO
Glutamate is the major excitatory neurotransmitter in the central nervous system. Glutamate transmission efficiency depends on the correct functionality and expression of a plethora of receptors and transporters, located both on neurons and glial cells. Of note, glutamate reuptake by dedicated transporters prevents its accumulation at the synapse as well as non-physiological spillover. Indeed, extracellular glutamate increase causes aberrant synaptic signaling leading to neuronal excitotoxicity and death. Moreover, extrasynaptic glutamate diffusion is strongly associated with glia reaction and neuroinflammation. Glutamate-induced excitotoxicity is mainly linked to an impaired ability of glial cells to reuptake and respond to glutamate, then this is considered a common hallmark in many neurodegenerative diseases, including Parkinson's disease (PD). In this review, we discuss the function of astrocytes and microglia in glutamate homeostasis, focusing on how glial dysfunction causes glutamate-induced excitotoxicity leading to neurodegeneration in PD.
Assuntos
Ácido Glutâmico/metabolismo , Ácido Glutâmico/toxicidade , Neuroglia/metabolismo , Neurotransmissores/metabolismo , Neurotransmissores/toxicidade , Doença de Parkinson/etiologia , Sistema X-AG de Transporte de Aminoácidos/metabolismo , Homeostase , Humanos , Inflamação , Doença de Parkinson/metabolismo , Receptores de Glutamato/metabolismoRESUMO
The neurotransmitter metabolite 3,4-dihydroxy-phenylglycolaldehyde (dopegal) damages neurons and the myocardium by protein cross-linking, resulting in conglomerations and cell death. We investigated this process on a synthetic scale, leading to the discovery of an Amadori-type rearrangement of dopegal in the reaction with several amino acids and neuropeptides. This alkylation also occurs with neurotransmitters, suggesting an influence of dopegal on neurochemical processes. The rearrangement occurs readily under physiological conditions.
Assuntos
Acetaldeído/análogos & derivados , Aminas Biogênicas/química , Neurotransmissores/química , Acetaldeído/química , Acetaldeído/toxicidade , Alquilação , Sistema Nervoso/efeitos dos fármacos , Neurotransmissores/toxicidade , Análise Espectral/métodosRESUMO
It is often unclear why some genetic mutations to a given gene contribute to neurological disorders and others do not. For instance, two mutations have previously been found to produce a dominant negative for TRESK, a two-pore-domain K+ channel implicated in migraine: TRESK-MT, a 2-bp frameshift mutation, and TRESK-C110R. Both mutants inhibit TRESK, but only TRESK-MT increases sensory neuron excitability and is linked to migraine. Here, we identify a new mechanism, termed frameshift mutation-induced alternative translation initiation (fsATI), that may explain why only TRESK-MT is associated with migraine. fsATI leads to the production of a second protein fragment, TRESK-MT2, which co-assembles with and inhibits TREK1 and TREK2, two other two-pore-domain K+ channels, to increase trigeminal sensory neuron excitability, leading to a migraine-like phenotype in rodents. These findings identify TREK1 and TREK2 as potential molecular targets in migraine and suggest that fsATI should be considered as a distinct class of mutations.
Assuntos
Potenciais de Ação/genética , Transtornos de Enxaqueca/patologia , Mutação/genética , Neurônios/fisiologia , Canais de Potássio de Domínios Poros em Tandem/genética , Potenciais de Ação/efeitos dos fármacos , Animais , Células Cultivadas , Modelos Animais de Doenças , Feminino , Expressão Gênica/genética , Células HEK293 , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Transtornos de Enxaqueca/induzido quimicamente , Transtornos de Enxaqueca/genética , Transtornos de Enxaqueca/fisiopatologia , Modelos Biológicos , Modelos Moleculares , Neurotransmissores/toxicidade , Óxido Nítrico/toxicidade , Oócitos , Canais de Potássio/genética , Canais de Potássio de Domínios Poros em Tandem/metabolismo , Ratos , Ratos Sprague-Dawley , XenopusRESUMO
In this study, we investigated the effect of inhaled mixtures of volatile organic compounds (VOCs) and carbon monoxide (CO) on neuroethology. Fifty 6-week-old male Kunming mice were exposed in five similar static chambers; zero (control) and four different doses of VOC and CO mixtures (G1-G4) for 10 consecutive days and 2 h/day. The compounds and concentrations were as follows: formaldehyde, benzene, toluene, xylene, and CO as 0.10 + 0.11 + 0.20 + 0.20 + 10.00 mg/m3, 0.20 + 0.22 + 0.40 + 0.40 + 20.00 mg/m3, 1.00 + 1.10 + 2.00 + 2.00 + 100.00 mg/m3, and 5.00 + 5.50 + 10.00 + 10.00 + 500.00 mg/m3, respectively, which corresponded to 1, 2, 10, and 50 times the indoor air quality standard in China. Morris water maze and grip strength tests were performed during the exposure experiment. One day following the final exposure, oxidative damage levels, monoamine neurotransmitters, monoamine oxidase (MAO), and morphology of mice brain were analyzed. Escape latency, dopamine, norepinephrine (NE), and serotonin decreased significantly, while total antioxidant capacity, glutathione peroxidase, and MAO increased significantly in G3 and G4. In addition, there were morphological changes and degeneration of neurons in the dentate gyrus regions of the hippocampus in G4. Results showed that the inhaled mixtures of VOCs and CO affected learning and memory of mice. The impairment of monoamine neurotransmitter associated with MAO may be one of the mechanisms of learning and memory impairment of the mice induced by the mixtures of VOCs and CO.
Assuntos
Encéfalo/efeitos dos fármacos , Monóxido de Carbono/toxicidade , Neurotransmissores/toxicidade , Compostos Orgânicos Voláteis/toxicidade , Poluição do Ar em Ambientes Fechados/efeitos adversos , Análise de Variância , Animais , Benzeno , China , Formaldeído , Aprendizagem/efeitos dos fármacos , Masculino , Memória/efeitos dos fármacos , Camundongos , Monoaminoxidase/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Distribuição Aleatória , Tolueno , XilenosRESUMO
Spontaneous activity represents an early, primitive form of motor activity within zebrafish embryos, providing a potential readout for identification of neuroactive compounds. However, despite use as an endpoint in chemical screens around the world, the predictive power and limitations of assays relying on spontaneous activity remain unclear. Using an improved high-content screening assay that increased throughput from 384 to 3072 wells per week, we screened a well-characterized library of 1280 pharmacologically active compounds (LOPAC1280) - 612 of which target neurotransmission - to identify which targets are detected using spontaneous activity as a readout. Results from this screen revealed that (1) 8% of the LOPAC1280 library was biologically active; (2) spontaneous activity was affected by compounds spanning a broad array of targets; (3) only 4% of compounds targeting neurotransmission impacted spontaneous activity; and (4) hypoactivity was observed for 100% of hits detected, including those that exhibit opposing mechanisms of action for the same target. Therefore, while this assay was able to rapidly identify potent neuroactive chemicals, these data suggest that spontaneous activity may lack the ability to discriminate modes of action for compounds interfering with neurotransmission, an issue that may be due to systemic uptake following waterborne exposure, persistent control variation, and/or interference with non-neurotransmission-related mechanisms.
Assuntos
Comportamento Animal/efeitos dos fármacos , Ensaios de Triagem em Larga Escala , Atividade Motora/efeitos dos fármacos , Sistema Nervoso/efeitos dos fármacos , Neurotransmissores/farmacologia , Bibliotecas de Moléculas Pequenas , Peixe-Zebra/embriologia , Animais , Animais Geneticamente Modificados , Mineração de Dados , Embrião não Mamífero/efeitos dos fármacos , Sistema Nervoso/embriologia , Sistema Nervoso/metabolismo , Neurotransmissores/toxicidade , Reprodutibilidade dos Testes , Transmissão Sináptica/efeitos dos fármacos , Fatores de Tempo , Imagem com Lapso de Tempo , Gravação em Vídeo , Peixe-Zebra/genética , Peixe-Zebra/metabolismoRESUMO
DON (6-diazo-5-oxo-l-norleucine), a glutamine antagonist, was demonstrated to exhibit analgesic, antibacterial, antiviral and anticancer properties. The study was performed to characterize its in vitro and in vivo genetic toxicity potential. DON was tested in the bacterial reverse mutation assay (Ames test) using Salmonella typhimurium tester strains (TA98, TA100, TA1535 and TA1537) and Escherichia coli tester strain (WP2 uvrA) with and without S9 and also with reductive S9. In addition, DON was tested for the chromosome aberrations in Chinese hamster ovary (CHO) cells with or without S9 to evaluate the clastogenic potential. Furthermore, DON was also evaluated for its in vivo clastogenic activity by detecting micronuclei in polychromatic erythrocyte (PCE) cells in bone marrow collected from the male mice dosed intravenously with 500, 100, 10, 1 and 0.1 mg/kg at 24 and 48-h post-dose. The Ames mutagenicity assay showed no positive mutagenic responses. However, the in vitro chromosome aberration assay demonstrated dose dependent statistically positive increase in structural aberrations at 4 and 20-h exposure without S9 and also at 4-h exposure with S9. The in vivo micronucleus assay also revealed a statistically positive response for micronucleus formation at 500, 100 and 10 mg/kg at 24 and 48-h post-dose. Thus, DON appears to be negative in the Ames test but positive in the in vitro chromosome aberration assay and in the in vivo micronucleus assay. In conclusion, the results indicate DON is a genotoxic compound with a plausible epigenetic mechanism.
Assuntos
Compostos Azo/toxicidade , Aberrações Cromossômicas/efeitos dos fármacos , Células Precursoras Eritroides/efeitos dos fármacos , Glutamina/antagonistas & inibidores , Mutagênicos/toxicidade , Neurotransmissores/toxicidade , Norleucina/análogos & derivados , Ativação Metabólica , Animais , Arocloros/farmacologia , Compostos Azo/administração & dosagem , Compostos Azo/metabolismo , Células CHO , Cricetinae , Cricetulus , Relação Dose-Resposta a Droga , Poluentes Ambientais/farmacologia , Masculino , Mesocricetus , Camundongos Endogâmicos ICR , Testes para Micronúcleos , Microssomos Hepáticos/efeitos dos fármacos , Microssomos Hepáticos/enzimologia , Microssomos Hepáticos/metabolismo , Testes de Mutagenicidade , Mutagênicos/administração & dosagem , Mutagênicos/metabolismo , Neurotransmissores/administração & dosagem , Neurotransmissores/metabolismo , Norleucina/administração & dosagem , Norleucina/metabolismo , Norleucina/toxicidade , Ratos Sprague-Dawley , Testes de Toxicidade AgudaRESUMO
Ibogaine is a plant alkaloid used as anti-addiction drug in dozens of alternative medicine clinics worldwide. Recently, alarming reports of life-threatening cardiac arrhythmias and cases of sudden death associated with the ingestion of ibogaine have accumulated. Using whole-cell patch clamp recordings, we assessed the effects of ibogaine and its main metabolite noribogaine on action potentials in human ventricular-like cardiomyocytes derived from induced pluripotent stem cells. Therapeutic concentrations of ibogaine and its long-lived active metabolite noribogaine significantly retarded action potential repolarization in human cardiomyocytes. These findings represent the first experimental proof that ibogaine application entails a cardiac arrhythmia risk for humans. In addition, they explain the clinically observed delayed incidence of cardiac adverse events several days after ibogaine intake. We conclude that therapeutic concentrations of ibogaine retard action potential repolarization in the human heart. This may give rise to a prolongation of the QT interval in the electrocardiogram and cardiac arrhythmias.
Assuntos
Potenciais de Ação/efeitos dos fármacos , Arritmias Cardíacas/induzido quimicamente , Diferenciação Celular , Ibogaína/toxicidade , Células-Tronco Pluripotentes Induzidas/efeitos dos fármacos , Miócitos Cardíacos/efeitos dos fármacos , Neurotransmissores/toxicidade , Transtornos Relacionados ao Uso de Substâncias/tratamento farmacológico , Arritmias Cardíacas/metabolismo , Arritmias Cardíacas/fisiopatologia , Células Cultivadas , Relação Dose-Resposta a Droga , Frequência Cardíaca/efeitos dos fármacos , Humanos , Ibogaína/análogos & derivados , Células-Tronco Pluripotentes Induzidas/metabolismo , Miócitos Cardíacos/metabolismo , Técnicas de Patch-Clamp , Medição de Risco , Fatores de TempoRESUMO
BACKGROUND: Potassium bromate (KBrO3) is widely used as a food additive and is a major water disinfection by-product. The present study reports the side effects of KBrO3 administration on the brain functions and behaviour of albino mice. METHODS: Animals were divided into three groups: control, low dose KBrO3 (100 mg/kg/day) and high dose KBrO3 (200 mg/kg/day) groups. RESULTS: Administration of KBrO3 led to a significant change in the body weight in the animals of the high dose group in the first, second and the last weeks while water consumption was not significantly changed. Neurobehavioral changes and a reduced Neurotransmitters levels were observed in both KBrO3 groups of mice. Also, the brain level of reduced glutathione (GSH) in KBrO3 receiving animals was decreased. Histological studies favoured these biochemical results showing extensive damage in the histological sections of brain of KBrO3-treated animals. CONCLUSIONS: These results show that KBrO3 has serious damaging effects on the central nervous system and therefore, its use should be avoided.
Assuntos
Bromatos/administração & dosagem , Administração Oral , Animais , Peso Corporal/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Bromatos/toxicidade , Relação Dose-Resposta a Droga , Aditivos Alimentares/administração & dosagem , Aditivos Alimentares/toxicidade , Glutationa/metabolismo , Masculino , Camundongos , Neurotransmissores/administração & dosagem , Neurotransmissores/toxicidade , Estresse Oxidativo/efeitos dos fármacosRESUMO
This study outlines the analysis of mitochondrial toxicity for a variety of pharmaceutical drugs extracted from Zhang et al. ((2009) Toxicol. In Vitro, 23, 134-140). These chemicals were grouped into categories based upon structural similarity. Subsequently, mechanistic analysis was undertaken for each category to identify the molecular initiating event driving mitochondrial toxicity. The mechanistic information elucidated during the analysis enabled mechanism-based structural alerts to be developed and combined together to form an in silico profiler. This profiler is envisaged to be used to develop chemical categories based upon similar mechanisms as part of the adverse outcome pathway paradigm. Additionally, the profiler could be utilized in screening large data sets in order to identify chemicals with the potential to induce mitochondrial toxicity.
Assuntos
Bases de Dados de Compostos Químicos , Mitocôndrias/efeitos dos fármacos , Anestésicos/química , Anestésicos/toxicidade , Anti-Infecciosos/química , Anti-Infecciosos/toxicidade , Anti-Inflamatórios não Esteroides/química , Anti-Inflamatórios não Esteroides/toxicidade , Ácidos e Sais Biliares/química , Ácidos e Sais Biliares/toxicidade , Humanos , Hipoglicemiantes/química , Hipoglicemiantes/toxicidade , Mitocôndrias/metabolismo , Neurotransmissores/química , Neurotransmissores/toxicidade , Relação Quantitativa Estrutura-Atividade , SoftwareRESUMO
Treatment of neonatal rats with the transient receptor potential vanilloid 1 (TRPV1) channel agonist, capsaicin, produces life-long loss of sensory neurons expressing TRPV1 channels. Previously it was shown that rats treated on day 2 of life with capsaicin had behavioural hyperactivity in a novel environment at 5-7 weeks of age and brain changes reminiscent of those found in subjects with schizophrenia. The objective of the present study was to investigate brain and behavioural responses of adult rats treated as neonates with capsaicin. It was found that the brain changes found at 5-7 weeks in rats treated as neonates with capsaicin persisted into adulthood (12 weeks) but were less in older rats (16-18 weeks). Increased prepulse inhibition (PPI) of acoustic startle was found in these rats at 8 and 12 weeks of age rather than the deficit commonly found in animal models of schizophrenia. Subjects with schizophrenia also have reduced flare responses to niacin and methylnicotinate proposed to be mediated by prostaglandin D2 (PGD2). Flare responses are accompanied by cutaneous plasma extravasation. It was found that the cutaneous plasma extravasation responses to methylnicotinate and PGD2 were reduced in capsaicin-treated rats. In conclusion, several neuroanatomical changes observed in capsaicin-treated rats, as well as the reduced cutaneous plasma extravasation responses, indicate that the role of TRPV1 channels in schizophrenia is worthy of investigation.
Assuntos
Encéfalo/efeitos dos fármacos , Encéfalo/crescimento & desenvolvimento , Capsaicina/toxicidade , Neurotransmissores/toxicidade , Canais de Cátion TRPV/agonistas , Estimulação Acústica , Animais , Animais Recém-Nascidos , Percepção Auditiva/efeitos dos fármacos , Percepção Auditiva/fisiologia , Encéfalo/patologia , Encéfalo/fisiopatologia , Feminino , Masculino , Atividade Motora/efeitos dos fármacos , Atividade Motora/fisiologia , Niacina , Ácidos Nicotínicos , Tamanho do Órgão , Inibição Pré-Pulso/efeitos dos fármacos , Inibição Pré-Pulso/fisiologia , Prostaglandina D2/administração & dosagem , Ratos Wistar , Reflexo de Sobressalto/efeitos dos fármacos , Reflexo de Sobressalto/fisiologia , Fenômenos Fisiológicos da Pele/efeitos dos fármacos , Canais de Cátion TRPV/metabolismoRESUMO
N-stearoyltyrosine (NsTyr), a synthesized anandamide (AEA) analogue, could exert potent neuroprotective effects on cerebral ischemia models both in vivo and in vitro via intervening in multiple injuries. Glutamate, a major excitatory neurotransmitter, plays a critical role during stroke/cerebral ischemia. In this study, we explored the protective effects of NsTyr on glutamate neurotoxicity in PC12 cells and investigated its underlying mechanisms. NsTyr treatment attenuated glutamate-induced oxidative toxicity in a dose-dependent manner and the best performance was observed at 10 µΜ. NsTyr treatment suppressed glutamate-induced upregulation of lipoxygenase 12/15 (LOX 12/15) activity and reactive oxygen species (ROS) elevation, attenuated the increase of BH3-interacting domain death agonist (Bid) in the mitochondria, prevented the loss of mitochondria membrane potential and consequently inhibited apoptosis-inducing factor (AIF) translocation into the nucleus. The results demonstrated that NsTyr could protect cells against AIF-mediated caspase-independent cell death induced by glutamate, which may be due to the blockage of Bid-mediated mitochondrial damage via reducing LOX 12/15 activity and ROS accumulation.
Assuntos
Fator de Indução de Apoptose/metabolismo , Ácido Glutâmico/toxicidade , Neuroprostanos/farmacologia , Neurotransmissores/fisiologia , Estresse Oxidativo/efeitos dos fármacos , Estresse Oxidativo/genética , Tirosina/análogos & derivados , Transporte Ativo do Núcleo Celular , Animais , Proteína Agonista de Morte Celular de Domínio Interatuante com BH3/metabolismo , Morte Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Ácido Glutâmico/fisiologia , Lipoxigenase/metabolismo , Mitocôndrias/genética , Neurotransmissores/toxicidade , Células PC12 , Ratos , Espécies Reativas de Oxigênio/metabolismo , Tirosina/farmacologia , Regulação para Cima/efeitos dos fármacosRESUMO
Recent gene association studies have implicated pituitary adenylate cyclase-activating peptide (PACAP) systems in several psychiatric disorders associated with stressor exposure, and we have argued that many of the behavioral consequences of repeated stressor exposure may depend on the expression of PACAP in the bed nucleus of the stria terminalis (BNST). One behavioral consequence of the activation of stress systems can be anorexia and subsequent weight loss, and both the activation of central PACAP systems as well as neuronal activity in the BNST have also been associated with anorexic states in rodents. Hence, we investigated the regulation of food and water intake and weight loss following BNST PACAP infusion. BNST PACAP38 dose-dependently decreased body weight, as well as food and water intake in the first 24 h following infusion. Because different BNST subregions differentially regulate stress responding, we further examined the effects of PACAP38 in either the anterior or posterior BNST. Anterior BNST PACAP38 infusion did not alter weight gain, whereas posterior PACAP38 infusion resulted in weight loss. PACAP38 infused into the lateral ventricles did not alter weight, suggesting that the effects of BNST-infused PACAP were not mediated by leakage into the ventricular system. These data suggest that PACAP receptor activation in posterior BNST subregions can produce anorexia and weight loss, and corroborate growing data implicating central PACAP activation in mediating the consequences of stressor exposure.
Assuntos
Anorexia/induzido quimicamente , Neurotransmissores/toxicidade , Polipeptídeo Hipofisário Ativador de Adenilato Ciclase/toxicidade , Núcleos Septais/efeitos dos fármacos , Núcleos Septais/fisiologia , Redução de Peso/efeitos dos fármacos , Análise de Variância , Animais , Relação Dose-Resposta a Droga , Vias de Administração de Medicamentos , Ingestão de Alimentos/efeitos dos fármacos , Estradiol/administração & dosagem , Feminino , Masculino , Ovariectomia , Ratos , Ratos Sprague-Dawley , Fatores SexuaisRESUMO
DJ-1 is an oxidative stress sensor that localizes to the mitochondria when the cell is exposed to oxidative stress. DJ-1 mutations that result in gene deficiency are linked to increased risk of Parkinson's disease (PD). Activation of microglial stress conditions that are linked to PD may result in neuronal death. We postulated that DJ-1 deficiency may increase microglial neurotoxicity. We found that down-regulation of DJ-1 in microglia using an shRNA approach increased cell sensitivity to dopamine as measured by secreted pro-inflammatory cytokines such as IL-1ß and IL-6. Furthermore, we discovered that DJ-1-deficient microglia had increased monoamine oxidase activity that resulted in elevation of intracellular reactive oxygen species and nitric oxide leading to increased dopaminergic neurotoxicity. Rasagaline, a monoamine oxidase inhibitor approved for treatment of PD, reduced the microglial pro-inflammatory phenotype and significantly reduced neurotoxicity. Moreover, we discovered that DJ-1-deficient microglia have reduced expression of triggering receptor expressed on myeloid cells 2 (TREM2), previously suggested as a risk factor for pro-inflammation in neurodegenerative diseases. Further studies of DJ-1-mediated cellular pathways in microglia may contribute useful insights into the development of PD providing future avenues for therapeutic intervention
Assuntos
Indanos/farmacologia , Microglia/metabolismo , Inibidores da Monoaminoxidase/farmacologia , Fármacos Neuroprotetores/farmacologia , Proteínas Oncogênicas/deficiência , Animais , Western Blotting , Linhagem Celular , Movimento Celular/efeitos dos fármacos , Citocinas/metabolismo , Dopamina/toxicidade , Ensaio de Imunoadsorção Enzimática , Inflamação/metabolismo , Camundongos , Microglia/efeitos dos fármacos , Neurotransmissores/toxicidade , Peroxirredoxinas , Fagocitose/efeitos dos fármacos , Fenótipo , Proteína Desglicase DJ-1 , RNA Interferente Pequeno , Espécies Reativas de Oxigênio/metabolismo , Reação em Cadeia da Polimerase em Tempo Real , Reação em Cadeia da Polimerase Via Transcriptase ReversaRESUMO
4BrABT (2-(4-Bromophenylamino)-5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazole) is a compound known for its interesting in vitro anticancer profile. 4BrABT inhibited proliferation and motility of several cancer cell lines in concentrations which were not toxic to normal cells. A major problem associated with cancer chemotherapy, but also caused by environmental factors such as pesticides, is neurotoxicity. Therefore, the aim of the presented study was an in vitro evaluation of the neuroprotective activity of this compound. 4BrABT activity (1-100 µM) was tested in cultures of mouse neurons, rat astrocytes and rat oligodendrocytes. A possible protective action of the compound in different neurodegenerative models, as serum deprivation (SD), excitotoxicity (presence of 500 µM glutamate in culture medium), as well as cisplatin toxicity (astroglia--50 µM and oligodendroglia--100 µM) was investigated. Cell viability in the tested cultures was assessed with the use of LDH and MTT methods. Moreover, 4BrABT ability to prevent the cisplatin-induced apoptosis in astrocyte and oligodendrocyte cultures was analysed after Hoechst 33342 fluorostaining. The obtained results indicate that 4BrABT was not toxic to neurons, astrocytes and oligodendrocytes. Moreover, a decrease in the neuronal LDH level was observed, which may suggest the ability of 4BrABT to act as a trophic agent. Furthermore, the protective action of the studied compound was shown in neuronal cultures exposed to neurotoxic conditions (presence of glutamate and trophic stress) and in cisplatin-treated astrocytes and oligodendrocytes. The expression of anticancer and neuroprotective activity raises hopes for the potential use of 4BrABT as a safe anticancer drug, or neuroprotective agent in chemotherapy-associated neurotoxicity.